loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X

List of Certificates of Suitability (CEPs) for cep_2020_234___rev_02 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 TEVA PHARMACEUTICAL INDUSTRIES LTD Tel Aviv - Jaffa IL (1)

filter

01 Quetiapine Fumarate, ID 3871 (1)

filter

01 Israel (1)

filter

01 Valid (1)

URL Supplier Web Content
CEP 2020-234 - Rev 02
Valid
Chemical
2023-12-19
2541
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for Certificates of Suitability (CEPs) for CEP 2020-234 - Rev 02 of Teva Pharmaceutical Industries Ltd Tel Aviv - Jaffa Il

Looking for Certificates of Suitability (CEPs) for CEP 2020-234 - Rev 02 of Teva Pharmaceutical Industries Ltd Tel Aviv - Jaffa Il 1

20

Teva Pharmaceutical Industries Ltd Tel Aviv - Jaffa Il, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for Teva API has over 350 products in its portfolio and is the leading international supplier of APIs.

One of their significant offerings is Quetiapine Fumarate, ID 3871, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2020-234 - Rev 02

This Chemical Type CEP, issued on December 19, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 2541 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY